tirzepatide and hormone replacement therapy In a woman on using oral micronized progesterone who starts (a GLP‑1 receptor agonist), should the progesterone dose be adjusted because delayed gastric emptying may reduce its absorption? Tirzepatide plus hormone therapy increases

Other classes of medications may have fewer side effects for people prone to headaches

This lack of change in renal parameters was unsurprising because of the short follow-up duration

In its standing guidance on unapproved GLP-1 drugs, the US FDA warned companies that have illegally sold unapproved drugs containing semaglutide, tirzepatide or retatrutide that are falsely labeled for research purposes or not for human consumption. The agency was specific that these products have been sold directly to consumers for human use with dosing instructions, which is to say the FDA understands perfectly well that the research only label is a fig leaf and has said so

Studies show that short- and long-term supplementation is safe and well tolerated in healthy individuals and in a number of patient populations, a paper released via Current Sports Medicine Reports asserted

Tomassoni D, Di Cesare Mannelli L, Bramanti V, et al

This catches fridge malfunctions, accidental door-ajar situations, and power outages before they compromise medication